Kaposi's sarcoma in renal transplant recipients: Experience at Johannesburg Hospital, 1966 - 1989 by Margolius, L et al.
,.__16 ~
Kaposi's sarcoma in renal transplant recipients
Experience at Johannesburg Hospital, 1966 - 1989
L. MARGOLIUS, M. STEIN, D. SPENCER, W. R. BEZWODA
Abstract Between August 1966 and December 1989, 989
renal transplant recipients were followed up at the
Renal Transplant Unit of Johannesburg Hospital.
Seventy-five (7%) patients developed a total of 95
malignancies of which 5 (6%) were Kaposi's sarco-
ma. All patients received immunosuppressive
agents; steroids, azathioprine andJor cyclosporin
A. Clinical presentations included both limited
skin involvement (1 patient) and disseminated
forms of the disease: necrotic oral lesions (1
patient); disseminated skin involvement and lung
metastases (1 patient); and widespread skin
lesions with lymphadenopathy (2 patients). Four
patients responded with complete tumour regres-
sion at all sites upon withdrawal of the immuno-
suppressive drugs. One patient suffered disease
progression, and immunosuppression was con-
tinued, albeit at reduced dosages. These cases
illustrate a relatively rare complication of
immunosuppressive therapy. However, complete
withdrawal of iInmunosuppressive drugs may
result in sustained complete regression, despite
the presence ofadvanced KS.
SAfrMedJ1994; 84: 16-17.
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aposi's sarcoma (KS) is a relatively common
malignancy in recipients of transplanted organs_
It is estimated to occur in 0,4 - 0,6% of indivi-
duals with organ grafts, a frequency 150 - 200 times that
of the general population.'
In renal transplant recipients, the incidence of KS is
reponed to be 3,4 - 6%, 400 - 500 times greater than
that seen in the general population. The risk of KS fol-
lowing renal transplantation is the same as in patients
with immunodeficiency states such as underlying malig-
nant lymphoma, patients receiving long-term cortico-
steroid therapy and patients with AIDS!
KS in renal transplant recipients is different from
that in patients with classic KS. Although transplant-
induced KS affects the skin, lymphadenopathy and vis-
ceral involvement are much more frequent. While the
immunological abnormalities and presence of visceral
disease make the condition resemble epidemic or AlDS-
associated KS,"< cessation of immunosuppressive
therapy has been reponed to facilitate regression ofKS.;
The rising incidence of solid organ transplantation is
expected to lead to an increasing occurrence of KS in
these patients.
The present study retrospectively reviews our experi-
ence with KS in renal transplant recipients followed up
at the Renal Transplant Unit of Johannesburg Hospital
over a period of 23 years.
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Patients and methods
ine hundred and eighty-nine renal transplant recipi-
ents were followed up in the Renal Transplant Unit of
Johannesburg Hospital between August 1966 and
December 1989. All patients received various schedules
of immunosuppressive drugs such as azathioprine,
cyclosporin-A and steroids. A .review of the records of
the Renal Transplant Unit and the Department of
Medical Oncology/Haematology identified 75 renal
transplant patients with a total of 95 malignancies. Five
(6%) of these had KS. The medical records of these 5
patients were reviewed in detail.
The clinical course of KS and response to therapy
were retrospectively analysed. When the histological
diagnosis had been established, metastatic work-up con-
sisting of blood chemistry analysis, chest radiography,
gastro-intestinal studies, abdominal and pelvic sono-
graphy and/or computed tomography was performed.
Results
Five (0,5%) adult male renal transplant patients de-
veloped KS. Their mean age at the time of diagnosis
was 47 years (range 43 - 53 years). Two patients were of
Caucasian origin (Ponuguese and Lebanese), 1 was
Asian, I black and 1 'coloured' . The underlying renal
diseases leading to haemodialysis, renal transplantation
and immunosuppressive treatment included chronic
glomerulonephritis (3 patients), diabetic renal failure Cl
patient) and Alpon's disease Cl patient).
Two patients were receiving therapy with azathio-
prine, cyclosporin A and corticosteroids, 2 received
cyclosporin together with steroids, and 1 patient was
treated with azathioprine and steroids.
The mean interval between transplantation and onset
of KS was 18 months (range 8 - 38 months). Further
clinical details are shown in Table 1. Patient No. 1 had
KS that was limited to the skin. The 4 other patients
presented with advanced KS: disseminated skin involve-
ment and lung metastases (No. 2), necrotic mouth
ulcers (No. 3), disseminated skin lesions and inguinal
lymphadenopathy (Nos 4 and 5 respectively).
Four patients were treated by means of withdrawal of
the immunosuppressive drugs while 1 patient continued
with the immunosuppressive regimen (cyclosporin A
plus steroids) albeit at reduced dosages. Additional
therapeutic approaches used included palliative radio-
therapy and cyclophosphamide in patients 2 and 4 and
interferon in patient 3.
The mean duration of follow-up of the KS patients
was 18 months (range 15 - 24 months). Response to
therapy is shown in Table 1.
Outcome (Table I)
Only patient No. 2 suffered disease progression. In this
instance immunosuppressive drugs had been continued.
. The patient died of disseminated KS. The other
patients' lesions disappeared upon return to the chronic
dialysis programme and discontinuation of immunosup-
pressive therapy. Patient No. 3 is alive, well and no
longer receiving dialysis. The other three deaths were
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KS =Kaposi's sarcoma; M =male.
TABLE I.
Clinical characteristics of renal transplant recipients with KS
Time from
Immune- transplant
Age/sex! suppressive toKS Category
Patient no. extraction drugs (months) ofKS
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441M1white Cyclosporin-A; 21 Disseminated
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not rumour-related but resulted from sepsis (patients 1
and 4) and intracerebral haemorrhage (patient 5).
Postmortem examination did not reveal any evidence of
KS.
Discussion
The cause of the increased frequency of KS among
renal transplant recipients is multifactorial: (l) genetic
predisposition, i.e. increased incidence of specific lll.A
types; (il) chronic immunostimulation in the presence of
T-cell dysfunction; (iil) proliferation of suppressor cells
with the production of specific growth factors; and (iv)
direct neoplastic action of immunosuppressive drugs
and the defective humoral and cell-mediated immunity
of uraemia have all been implicated.1,.,.,'
The commonly used combination of azathioprine
and steroids was believed initially to be of prime impor-
tance in the aetiology of transplant-related KS.2,4
The majority of patients treated with this combination
develop low helper (CD:) lymphocyte counts,
depressed helper/suppressor (CD::CD;) ratios, low
immunoglobulin levels and anergy to skin test.
Following the discontinuation of these drugs, a partial
restoration of immune function2,8,. can be demonstrated.
Cyclosporin A has an inhibitory effect on T -helper
cells."'o Engraftment is favoured and graft survival
improved. An apparent increase in the incidence of lym-
phoma, skin cancer, multiple myeloma, mycosis fun-
goides and thymoma has followed the widespread usage
of cydosporin A for post-transplant immunosuppres-
sion. lO Recently, KS has been described more frequently
in patients treated with cyclosporin A than in patients
treated with conventional immunosuppressive therapy
(10% v. 3% of all neoplasms)."·13 These patients have
more aggressive disease, similar to that seen in AIDS-
related KS:,Il-13 A biological similarity to AIDS-asso-
ciated KS is indicated in a recent ultrastrucrural study
reporting the occurrence of abnormal intracytoplasmic
structures in patients treated with cydosporin A but not
in azathioprine-steroid-treated cohorts. These strlicrures
are similar to those observed in the AIDS-related form
of the disease.'· The high incidence of disseminated KS
in our series may be related to the use of cydosporin A.
In conclusion, our small study provided further sup-
port for the role of immunosuppressive drugs in the
pathogenesis of immunosuppression-induced KS. Due
to the increased use of cydosporin A in solid organ
transplantation, a high incidence of the disseminated
form of KS is to be expected. Withdrawal of immuno-
suppressive drugs can bring about complete regression,
even in advanced KS. Unfortunately discontinuation of
the drugs caused rejection of the transplanted kidney in
3 of our patients, necessitating a return to a chronic
dialysis programme in each instance.
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